Prof Dr. Mohamed Attia shafie, at Faculty of Pharmacy,Egypt
PROFILE
🎓Early Academic Pursuits :
Professor Mohamed Attia Shafie began his academic journey at Assiut University, Egypt, where he pursued his Bachelor’s degree in Pharmacy and Pharmaceutical Chemistry, graduating in 1969. His interest in the field propelled him to further his education at the same institution, where he obtained a Master’s degree in Pharmaceutics in 1972. His research focused on the interactions between plastic containers and certain liquid pharmaceutical preparations, highlighting his early engagement with the critical aspects of pharmaceutical formulation.
In pursuit of deeper knowledge and expertise, Professor Attia Shafie moved to the First Medical Institute in Moscow, USSR, to complete his Ph.D. in 1978. His doctoral research on the formulation of ophthalmic preparations included extensive studies on the physico-chemical properties and pharmacokinetics of an ophthalmic ointment containing sulfapyridine and hydrocortisone acetate. This foundation set the stage for his future contributions to the field of pharmaceutics.
🏫Professional Endeavors :
Professor Attia Shafie’s professional career spans several decades, primarily focused on teaching and research in the field of pharmaceutics. He has held numerous esteemed positions at various academic institutions. Currently, he is a Professor of Pharmaceutics at the Faculty of Pharmacy, Assiut University, where he has been teaching since 2011. He is responsible for imparting knowledge on topical preparations to students and has made significant contributions to curriculum development.
Before his current role, he served as the Head of the Pharmaceutical Technology Department at the German University in Cairo from 2006 to 2011, where he taught quality assurance and current good manufacturing practices (cGMP). His leadership extended to Assiut University, where he was the Professor and Head of the Pharmaceutics Department from 2002 to 2006, teaching courses in biopharmaceutics and dosage form design.
In addition to his academic roles, Professor Attia has garnered experience in the pharmaceutical industry. He worked as a consultant for Liptis Pharmaceuticals and Cid Pharmaceutical Company, where he contributed to product development and quality control from 2004 to 2006. He also served as a Production Manager at T3A Pharmaceutical Company from 1999 to 2000, managing the production of various pharmaceutical dosage forms.
🔬Contributions and Research Focus :
Throughout his career, Professor Attia Shafie has made substantial contributions to pharmaceutical sciences, particularly in the areas of ophthalmic preparations, buccal delivery, and the oral delivery of proteins and peptides. His research has led to the development of innovative formulations, including prednisolone-loaded cationic nanoemulsions for uveitis management, and Sertaconazole-PLGA nanoparticles for managing ocular keratitis.
His publication record is extensive, with numerous articles in reputable journals such as the Journal of Drug Delivery Science and Technology and Pharmaceutics. His work on chitosan nanoparticles for ocular delivery and the formulation of topical delivery systems for fungal infections highlights his commitment to advancing drug delivery technologies.
🏆Accolades and Recognition :
Professor Attia Shafie’s contributions to the field have been widely recognized. His research has not only advanced the understanding of drug delivery systems but has also significantly influenced clinical practices in ophthalmology. His published works are frequently cited, reflecting his impact on both academia and the pharmaceutical industry. His ability to bridge the gap between theoretical research and practical application has earned him a reputation as a leading expert in pharmaceutics.
🌍Impact and Influence :
Professor Attia Shafie’s impact extends beyond research and teaching; he has influenced a generation of pharmacy students and professionals. His emphasis on quality assurance and formulation design has shaped the curricula of various pharmacy programs. By mentoring students and guiding them through their academic journeys, he has fostered a new generation of pharmacists and researchers who are well-equipped to tackle future challenges in the pharmaceutical field.
His work has also contributed to the development of safer and more effective pharmaceutical products, thereby enhancing patient care and outcomes. Through collaborations with pharmaceutical companies, he has facilitated the translation of research findings into practical solutions that address real-world health issues.